electroCore, Inc. (NASDAQ:ECOR – Get Free Report) has received an average rating of “Hold” from the five research firms that are currently covering the company, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, two have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $22.00.
ECOR has been the subject of a number of research reports. Wall Street Zen raised shares of electroCore from a “sell” rating to a “hold” rating in a research note on Saturday, November 8th. Zacks Research lowered shares of electroCore from a “hold” rating to a “strong sell” rating in a research report on Wednesday, January 28th. HC Wainwright reduced their price objective on electroCore from $25.00 to $18.00 and set a “buy” rating on the stock in a research note on Monday, January 26th. Weiss Ratings reiterated a “sell (d-)” rating on shares of electroCore in a report on Monday, December 29th. Finally, Brookline Capital Acquisition upgraded electroCore to a “strong-buy” rating in a report on Tuesday, February 3rd.
Check Out Our Latest Analysis on electroCore
electroCore Price Performance
Institutional Trading of electroCore
A number of institutional investors have recently made changes to their positions in ECOR. NewEdge Advisors LLC increased its stake in shares of electroCore by 857.9% in the first quarter. NewEdge Advisors LLC now owns 161,955 shares of the company’s stock worth $1,083,000 after buying an additional 145,047 shares during the period. Tejara Capital Ltd purchased a new stake in electroCore during the 4th quarter valued at $450,000. DRW Securities LLC bought a new stake in electroCore in the 4th quarter worth $264,000. Cubist Systematic Strategies LLC purchased a new position in shares of electroCore in the first quarter valued at about $153,000. Finally, Jane Street Group LLC raised its stake in shares of electroCore by 114.4% during the first quarter. Jane Street Group LLC now owns 36,726 shares of the company’s stock valued at $246,000 after acquiring an additional 19,599 shares during the last quarter. Hedge funds and other institutional investors own 26.74% of the company’s stock.
About electroCore
electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.
The company’s lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.
See Also
- Five stocks we like better than electroCore
- Silver Crossed $100: Is the $500 surge next? (Join us March 4)
- America’s 1776 happening again
- Unlocked: Elon Musk’s Next Big IPO
- Silver paying 20% dividend. Plus 68% share gains
- REVEALED: Something Big Happening Behind White House Doors
Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.
